Results 41 to 50 of about 407,809 (349)

Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells

open access: yesFEBS Letters, EarlyView.
Imeglimin, at clinically relevant concentrations, inhibits vesicular ATP accumulation and release from hepatic stellate cells, thereby attenuating purinergic signaling and reducing fibrogenic activation. This mechanism reveals a newly identified antifibrotic action of imeglimin beyond glycemic control.
Seiji Nomura   +8 more
wiley   +1 more source

Causes of death in Tonga: quality of certification and implications for statistics

open access: yesPopulation Health Metrics, 2012
Background Detailed cause of death data by age group and sex are critical to identify key public health issues and target interventions appropriately. In this study the quality of local routinely collected cause of death data from medical certification ...
Carter Karen   +6 more
doaj   +1 more source

Medical certification of cause of death during COVID-19 pandemic – a challenging scenario

open access: yesJournal of Family Medicine and Primary Care, 2020
Death certificate data is used to monitor local, regional and national mortality trend and is helpful in improving public health as well as public safety.
Deepak Juyal   +5 more
doaj   +1 more source

Children’s death survey using death certificates in the Chiba prefecture

open access: yesForensic Science International: Reports, 2021
In recent years, Child Death Review (CDR) has attracted attention in Japan. It is necessary to consider not only hospital deaths but also out-of-hospital deaths.
Shumari Urabe   +6 more
doaj   +1 more source

Accuracy of death certification [PDF]

open access: yesBritish Journal of Psychiatry, 2011
The death certificate allows underlying conditions leading to the cause of death, as well as other significant conditions unrelated to the immediate cause of death, to be listed. Perusal of statistics of the causes of death is instructive. The list of drugs in the Office for National Statistics’
openaire   +3 more sources

Completing the Revised Death Certificate, [PDF]

open access: yes, 2011
The Iowa Office of the State Medical Examiner (IOSME) has received many questions regarding completion of the revised death certificate.

core  

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Uncertainties in death certification [PDF]

open access: yesBritish Journal of General Practice, 2012
Death is one of life’s few certainties, and most GPs will inevitably preside over a few patient deaths each year. Indeed, the apotheosis of the ‘good death’ could be the patient who dies at home, dignified and pain-free following well-coordinated interdisciplinary palliative care.1 Given that around three-quarters of people express a wish to die at ...
Simon Minkoff, Edin Lakasing
openaire   +3 more sources

Primary Care to the Rescue, Again! Autopsy and the Death Certificate [PDF]

open access: yes, 2017
An pre and post testing, an educational module, a presentation, and a dot phrase were developed to improve providers\u27 knowledge of the hospital autopsy and the correct completion of death certificates.https://scholarworks.uvm.edu/fmclerk/1317 ...
Ryan, Emily E
core   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy